Mandsaur IPA branch celebrates National Pharmacy Week 2001
B R Nahata College of Pharmacy celebrated the National Pharmacy Week 2001 on the eve of newly inaugurated ‘‘Mandsaur Local Branch of IPA’’.
Fabtech: A Winner in the Making
Amongst the few breakthrough technological products which Fabtech has introduced includes Bag-in Bag-out Filters, Double Skin Terminal Boxes and soon to come Modular Panels
Dr Udupa wins APTI’s principal of the year award
The Association of Pharmaceutical Teachers of India (APTI) has bestowed ‘‘Principal of the Year Award 2001’’ to Dr Nayanabhirama Udupa, principal, College of Pharmaceutical Sciences, Manipal, Karnataka.
Bayer prunes Cipro payment to Ranbaxy by 15 m
Bayer AG has decided to bring down the size of the milestone payments to Ranbaxy for its one-a-day ciprofloxacine brand, Cipro OD by $15 million.
Accelrys, GSK tie-up for data analyser
Accelrys, a wholly-owned subsidiary of Pharmacopeia, Inc. and GlaxoSmithKline (GSK) announced that they have collaborated to produce a ‘‘Hits and Leads Chemically Aware Spreadsheet’’ to enable GSK scientists to access, analyze, and visualise the vast amounts of chemical and biological data stored in GSK’s R&D databases.
Kelvin Cryosystems announces 3G reactor system
The 3rd Generation of Kelvin’s Cryogenically Cooled Reactor (CCR) Systems was started up in the summer of 2001, with continuous reliable operation since August.
New delivery system for Loratadine
Flemington Pharmaceu-tical Corp. announced the completion of a pilot feasibility study testing its patented immediate release lingual spray delivery system for administration of Loratadine, the active ingredient in Schering-Plough’s Claritin.
Watson-Marlow Bredel offers the 500 series pump for chemical applications
Watson-Marlow Bredel, the leading manufacturer of peristaltic pumps, offers the 500 Series pump for chemical applications.
Paclitaxel use by breast cancer patients tied to pneumonitis after radiotherapy
Breast cancer patients treated with paclitaxel and radiation therapy (RT) are much more likely to develop pneumonitis than similar patients treated with a different chemotherapeutic agent, according to a report published in the latest issue of the Journal of the National Cancer Institute.